Free Trial

Eliem Therapeutics (ELYM) Institutional Ownership

→ The #1 Crypto for AI (From Weiss Ratings) (Ad)
Free ELYM Stock Alerts
$8.95
-0.37 (-3.97%)
(As of 05/9/2024 ET)
Compare
Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media

Institutional Ownership Changes (13F Filings) for Eliem Therapeutics (NASDAQ:ELYM)

Current
Institutional Ownership
Percentage
69.76%
Number of
Institutional Buyers
(last 12 months)
4
Total
Institutional Inflows
(last 12 months)
$2.07M
Number of
Institutional Sellers
(last 12 months)
2
Total
Institutional Outflows
(last 12 months)
$1.19M
Get ELYM Insider Trade Alerts

Want to know when executives and insiders are buying or selling Eliem Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

ELYM Institutional Buying and Selling by Quarter

Eliem Therapeutics Major Shareholders & Ownership History

Export to Excel
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
4/23/2024 BML Capital Management LLC2,193,742$6.01M4.0%+0.6%7.914%
1/30/2024 BML Capital Management LLC2,180,000$5.89M4.4%+12.5%7.907%
1/26/2024Cerity Partners LLC13,821$37K0.0%N/A0.050%
11/13/2023Silverarc Capital Management LLC121,110$319K0.1%-75.5%0.447%
10/23/2023 BML Capital Management LLC1,938,263$5.10M4.7%+22.4%7.155%
8/15/2023Silverarc Capital Management LLC494,089$1.38M0.4%+1.7%1.830%
8/14/2023Driehaus Capital Management LLC810,593$2.27M0.0%+20.3%3.003%
7/24/2023 BML Capital Management LLC1,583,170$4.43M4.0%-4.5%5.866%
4/14/2023 BML Capital Management LLC1,658,170$4.81M4.2%-9.1%6.148%
2/14/2023Driehaus Capital Management LLC551,942$2.03M0.0%+58.3%2.077%
2/13/2023 BML Capital Management LLC1,825,134$6.70M6.4%N/A6.869%
2/1/2023Bank of Montreal Can25,244$93K0.0%N/A0.095%
11/8/2022Atom Investors LP67,074$217K0.1%+154.9%0.252%
10/28/2022Silverarc Capital Management LLC402,088$1.30M0.4%-43.6%1.513%
8/16/2022Parkwood LLC67,202$67K0.2%+63.4%0.253%
7/25/2022Silverarc Capital Management LLC713,009$2.15M0.7%+707.7%2.684%
5/12/2022Monashee Investment Management LLC227,201$1.91M0.6%-24.3%0.855%
5/9/2022Qube Research & Technologies Ltd15,874$133K0.0%N/A0.060%
2/19/2022Woodline Partners LP373,368$3.91M0.1%-3.6%1.406%
2/15/2022Samlyn Capital LLC1,703,546$17.82M0.2%+1.3%6.417%
2/11/2022Parkwood LLC30,609$320K0.1%N/A0.115%
2/7/2022Monashee Investment Management LLC300,000$3.14M0.8%-1.7%1.130%
2/2/2022 New York State Common Retirement Fund3,359$35K0.0%N/A0.013%
1/28/2022 Allspring Global Investments Holdings LLC2,880$30K0.0%N/A0.011%
12/29/2021Hudson Bay Capital Management LP100,000$1.80M0.0%N/A0.377%
11/15/2021Tudor Investment Corp Et Al287,294$5.17M0.0%N/A1.082%
11/15/2021RA Capital Management L.P.13,150,849$236.45M3.3%N/A49.536%
11/15/2021 Caas Capital Management LP75,000$1.35M0.0%N/A0.283%
11/12/2021Geode Capital Management LLC76,904$1.38M0.0%N/A0.290%
11/10/2021Goldman Sachs Group Inc.165,952$2.98M0.0%N/A0.625%
11/9/2021BlackRock Inc.332,126$5.97M0.0%N/A1.251%
11/9/2021Monashee Investment Management LLC305,233$5.49M1.0%N/A1.150%
11/4/2021Deutsche Bank AG4,063$73K0.0%N/A0.015%
(Data available from 1/1/2016 forward)

ELYM Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of ELYM shares?

During the previous two years, 9 institutional investors and hedge funds held shares of Eliem Therapeutics. The most heavily invested institutionals were BML Capital Management LLC ($6.01M), Driehaus Capital Management LLC ($2.27M), Monashee Investment Management LLC ($1.91M), Silverarc Capital Management LLC ($319K), Atom Investors LP ($217K), Qube Research & Technologies Ltd ($133K), and Bank of Montreal Can ($93K).Learn more on ELYM's institutional investors.

What percentage of Eliem Therapeutics stock is owned by institutional investors?

69.76% of Eliem Therapeutics stock is owned by institutional investors. Learn more on ELYM's institutional investor holdings.

Which institutional investors have been buying Eliem Therapeutics stock?

The following institutional investors have purchased Eliem Therapeutics stock in the last 24 months: BML Capital Management LLC ($2.44M), Silverarc Capital Management LLC ($632.86K), Driehaus Capital Management LLC ($340.28K), Atom Investors LP ($40.77K), Parkwood LLC ($26.07K), Bank of Montreal Can ($25.24K), and Qube Research & Technologies Ltd ($15.87K).

How much institutional buying is happening at Eliem Therapeutics?

Institutional investors have bought a total of 3,530,623 shares in the last 24 months. This purchase volume represents approximately $11.84M in transactions.

Which Eliem Therapeutics major shareholders have been selling company stock?

The following institutional investors have sold Eliem Therapeutics stock in the last 24 months: Silverarc Capital Management LLC ($683.90K), BML Capital Management LLC ($241.96K), and Monashee Investment Management LLC ($72.80K).

How much institutional selling is happening at Eliem Therapeutics?

Institutional investors have sold a total of 998,663 shares in the last 24 months. This volume of shares sold represents approximately $3.29M in transactions.


Related Companies:
This page (NASDAQ:ELYM) was last updated on 5/9/2024 by MarketBeat.com Staff

From Our Partners
The 2024 Gold Rush: Unleashing Market Potential
Priority Gold
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
Dems have chosen Biden replacement?
Paradigm Press
The A.I. story nobody is telling you (Read ASAP)
TradeSmith
Trump’s “Tax Free” Retirement Strategy
Gold Safe Exchange
The Crypto 9-5 Escape Plan
Crypto 101 Media
Urgent Nvidia Warning
Altimetry
The “Next Bitcoin”? 10 CENT Crypto Set to Explode
True Market Insiders